Literature DB >> 19908966

Interactive cytokine regulation of synoviocyte lubricant secretion.

Megan E Blewis1, Brian J Lao, Barbara L Schumacher, William D Bugbee, Robert L Sah, Gary S Firestein.   

Abstract

Cytokine regulation of synovial fluid (SF) lubricants, hyaluronan (HA), and proteoglycan 4 (PRG4) is important in health, injury, and disease of synovial joints, and may also provide powerful regulation of lubricant secretion in bioreactors for articulating tissues. This study assessed lubricant secretion rates by human synoviocytes and the molecular weight (MW) of secreted lubricants in response to interleukin (IL)-1beta, IL-17, IL-32, transforming growth factor-beta 1 (TGF-beta1), and tumor necrosis factor-alpha (TNF-alpha), applied individually and in all combinations. Lubricant secretion rates were assessed using ELISA and binding assays, and lubricant MW was assessed using gel electrophoresis and Western blotting. HA secretion rates were increased approximately 40-fold by IL-1beta, and increased synergistically to approximately 80-fold by the combination of IL-1beta + TGF-beta1 or TNF-alpha + IL-17. PRG4 secretion rates were increased approximately 80-fold by TGF-beta1, and this effect was counterbalanced by IL-1beta and TNF-alpha. HA MW was predominantly <1 MDa for controls and individual cytokine stimulation, but was concentrated at >3 MDa after stimulation by IL-1beta + TGF-beta1 + TNF-alpha to resemble the distribution in human SF. PRG4 MW was unaffected by cytokines and similar to that in human SF. These results contribute to an understanding of the relationship between SF cytokine and lubricant content in health, injury, and disease, and provide approaches for using cytokines to modulate lubricant secretion rates and MW to help achieve desired lubricant composition of fluid in bioreactors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19908966      PMCID: PMC2862605          DOI: 10.1089/ten.TEA.2009.0210

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  48 in total

1.  Interleukin-17 enhances tumor necrosis factor alpha-induced synthesis of interleukins 1,6, and 8 in skin and synovial fibroblasts: a possible role as a "fine-tuning cytokine" in inflammation processes.

Authors:  Y Katz; O Nadiv; Y Beer
Journal:  Arthritis Rheum       Date:  2001-09

2.  Hyaluronan production in human rheumatoid fibroblastic synovial lining cells is increased by interleukin 1 beta but inhibited by transforming growth factor beta 1.

Authors:  M Kawakami; K Suzuki; Y Matsuki; T Ishizuka; T Hidaka; T Konishi; M Matsumoto; K Kataharada; H Nakamura
Journal:  Ann Rheum Dis       Date:  1998-10       Impact factor: 19.103

3.  Lubricin is a product of megakaryocyte stimulating factor gene expression by human synovial fibroblasts.

Authors:  G D Jay; D E Britt; C J Cha
Journal:  J Rheumatol       Date:  2000-03       Impact factor: 4.666

4.  Bioregulation of lubricin expression by growth factors and cytokines.

Authors:  A R C Jones; C R Flannery
Journal:  Eur Cell Mater       Date:  2007-03-20       Impact factor: 3.942

5.  Continuous passive motion applied to whole joints stimulates chondrocyte biosynthesis of PRG4.

Authors:  G E Nugent-Derfus; T Takara; J K O'neill; S B Cahill; S Görtz; T Pong; H Inoue; N M Aneloski; W W Wang; K I Vega; T J Klein; N D Hsieh-Bonassera; W C Bae; J D Burke; W D Bugbee; R L Sah
Journal:  Osteoarthritis Cartilage       Date:  2006-12-08       Impact factor: 6.576

6.  Cytokines in chronic inflammatory arthritis. VI. Analysis of the synovial cells involved in granulocyte-macrophage colony-stimulating factor production and gene expression in rheumatoid arthritis and its regulation by IL-1 and tumor necrosis factor-alpha.

Authors:  J M Alvaro-Gracia; N J Zvaifler; C B Brown; K Kaushansky; G S Firestein
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

7.  Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions.

Authors:  Alaa Afify; Lin-Chang Lynne; Lydia Howell
Journal:  Diagn Cytopathol       Date:  2007-02       Impact factor: 1.582

8.  Effects of pro- and anti-inflammatory cytokines and nitric oxide donors on hyaluronic acid synthesis by synovial cells from patients with rheumatoid arthritis.

Authors:  Camille Chenevier-Gobeaux; Séverine Morin-Robinet; Hervé Lemarechal; Serge Poiraudeau; Jean-Charles O G Ekindjian; Didier Borderie
Journal:  Clin Sci (Lond)       Date:  2004-09       Impact factor: 6.124

9.  Binding of haptoglobin, inter-alpha-trypsin inhibitor, and alpha 1 proteinase inhibitor to synovial fluid hyaluronate and the influence of these proteins on its degradation by oxygen derived free radicals.

Authors:  N Hutadilok; P Ghosh; P M Brooks
Journal:  Ann Rheum Dis       Date:  1988-05       Impact factor: 19.103

10.  Chondrocytes, synoviocytes and dermal fibroblasts all express PH-20, a hyaluronidase active at neutral pH.

Authors:  Hafida El Hajjaji; Ada Asbury Cole; Daniel-Henri Manicourt
Journal:  Arthritis Res Ther       Date:  2005-04-04       Impact factor: 5.156

View more
  16 in total

1.  Pathogenetic mechanisms of posttraumatic osteoarthritis: opportunities for early intervention.

Authors:  William C Kramer; Kelly J Hendricks; Jinxi Wang
Journal:  Int J Clin Exp Med       Date:  2011-10-21

Review 2.  Engineering lubrication in articular cartilage.

Authors:  Sean M McNary; Kyriacos A Athanasiou; A Hari Reddi
Journal:  Tissue Eng Part B Rev       Date:  2012-01-06       Impact factor: 6.389

Review 3.  Cellular and molecular perspectives in rheumatoid arthritis.

Authors:  Douglas J Veale; Carl Orr; Ursula Fearon
Journal:  Semin Immunopathol       Date:  2017-05-15       Impact factor: 9.623

Review 4.  Synovial tissue research: a state-of-the-art review.

Authors:  Carl Orr; Elsa Vieira-Sousa; David L Boyle; Maya H Buch; Christopher D Buckley; Juan D Cañete; Anca I Catrina; Ernest H S Choy; Paul Emery; Ursula Fearon; Andrew Filer; Danielle Gerlag; Frances Humby; John D Isaacs; Søren A Just; Bernard R Lauwerys; Benoit Le Goff; Antonio Manzo; Trudy McGarry; Iain B McInnes; Aurélie Najm; Constantino Pitzalis; Arthur Pratt; Malcolm Smith; Paul P Tak; Rogier Thurlings; João E Fonseca; Douglas J Veale; Sander W Tas
Journal:  Nat Rev Rheumatol       Date:  2017-07-13       Impact factor: 20.543

5.  Effects of equine joint injury on boundary lubrication of articular cartilage by synovial fluid: role of hyaluronan.

Authors:  Jennifer M Antonacci; Tannin A Schmidt; Lisa A Serventi; Matthew Z Cai; YuYu L Shu; Barbara L Schumacher; C Wayne McIlwraith; Robert L Sah
Journal:  Arthritis Rheum       Date:  2012-09

Review 6.  A systems biology approach to synovial joint lubrication in health, injury, and disease.

Authors:  Alexander Y Hui; William J McCarty; Koichi Masuda; Gary S Firestein; Robert L Sah
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2011-08-08

7.  Semi-permeable membrane retention of synovial fluid lubricants hyaluronan and proteoglycan 4 for a biomimetic bioreactor.

Authors:  Megan E Blewis; Brian J Lao; Kyle D Jadin; William J McCarty; William D Bugbee; Gary S Firestein; Robert L Sah
Journal:  Biotechnol Bioeng       Date:  2010-05-01       Impact factor: 4.530

8.  Transcription, translation, and function of lubricin, a boundary lubricant, at the ocular surface.

Authors:  Tannin A Schmidt; David A Sullivan; Erich Knop; Stephen M Richards; Nadja Knop; Shaohui Liu; Afsun Sahin; Raheleh Rahimi Darabad; Sheila Morrison; Wendy R Kam; Benjamin D Sullivan
Journal:  JAMA Ophthalmol       Date:  2013-06       Impact factor: 7.389

Review 9.  Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes.

Authors:  Gyrid Nygaard; Gary S Firestein
Journal:  Nat Rev Rheumatol       Date:  2020-05-11       Impact factor: 20.543

10.  cAMP attenuates TGF-β's profibrotic responses in osteoarthritic synoviocytes: involvement of hyaluronan and PRG4.

Authors:  Marwa M Qadri; Gregory D Jay; Rennolds S Ostrom; Ling X Zhang; Khaled A Elsaid
Journal:  Am J Physiol Cell Physiol       Date:  2018-06-13       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.